NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT07418749 2026-02-18A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical CancerSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 Not yet recruiting398 enrolled
NCT03635567 2026-02-04KEYNOTE-826Merck Sharp & Dohme LLCPhase 3 Completed617 enrolled 29 charts 1 FDA
NCT00980954 2025-12-31Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical HysterectomyRadiation Therapy Oncology GroupPhase 3 Completed236 enrolled 28 charts